A San Diego-based startup biotech company founded by Andrew Young, M.D., Ph.D. developing novel therapeutic treatments for diabetes and obesity. A proof of concept human clinical trial was completed successfully in 2009. The Series A financing was led by Mesa Verde Venture Partners.
A Utah-based biomarker discovery company focusing on novel, patentable diagnostic testing tools and processes with a focus on the commercialization of diagnostics for Autism and Multiple Sclerosis. A $5.8 million Series A round was led by Sanderling Ventures and vSpring Capital.
A San Diego-based specialty pharmaceutical company aimed at reformulation of an existing COPD drugs, delivered in a nebulized format. Mesa Verde lead a convertible note financing at a discount into the Series A round of $30 million led by Canaan Partners. In September 2012, Elevation was acquired for up to $430 million by Sunovian.
A Tucson, Arizona and San Diego-based company developing advanced and innovative infusion pump technology for fluid delivery systems based upon electro-activated polymers. Mesa Verde participated in the Series A financing.
A San Diego-based company that develops and offers innovative technologies that stabilize biological materials at room temperature. Mesa Verde participated in the Series C financing as the company's first institutional investor.
An Albuquerque and San Diego-based discovery driven, patient focused CLIA registered molecular diagnostics laboratory. Exagen has a growing menu of proprietary, largely internally developed genomic tests to enable more accurate diagnosis of Lupus and Rheumatoid Arthritis. Mesa Verde participated in the Series A and B financing.